These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24961832)

  • 41. Insulin pumps in hospital: a guide for the generalist physician.
    Evans K
    Clin Med (Lond); 2013 Jun; 13(3):244-7. PubMed ID: 23760696
    [TBL] [Abstract][Full Text] [Related]  

  • 42. "Lipoblastoma-like" lipoatrophy induced by human insulin: morphological evidence for local dedifferentiation of adipocytes?
    Jermendy G; Nádas J; Sápi Z
    Diabetologia; 2000 Jul; 43(7):955-6. PubMed ID: 10952472
    [No Abstract]   [Full Text] [Related]  

  • 43. Continuous subcutaneous insulin infusion (CSII) pumps.
    Valla V
    Adv Exp Med Biol; 2012; 771():414-9. PubMed ID: 23393693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipoatrophy induced by subcutaneous insulin infusion: ultrastructural analysis and gene expression profiling.
    Milan G; Murano I; Costa S; Pianta A; Tiengo C; Zulato E; Centobene C; Bruttomesso D; Cinti S; Vettor R
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3126-32. PubMed ID: 20484470
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Severe lipoatrophy with human insulin: successfully treated by CSII.
    Chantelau E; Reuter M; Schotes S; Starke AA
    Diabet Med; 1993 Jul; 10(6):580-1. PubMed ID: 8365099
    [No Abstract]   [Full Text] [Related]  

  • 46. [Insulin lipoatrophy and its elimination through the use of monocomponent insulin].
    Maaz E
    Z Gesamte Inn Med; 1976 Nov; 31(22):941-5. PubMed ID: 1035452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lipoatrophy induced by subcutaneous administration of octreotide in the treatment of acromegaly.
    Atmaca A; Erbas T
    Exp Clin Endocrinol Diabetes; 2005 Jun; 113(6):340-3. PubMed ID: 15977102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Images in clinical medicine. Injection-site lipoatrophy.
    Sackey AH
    N Engl J Med; 2009 Nov; 361(19):e41. PubMed ID: 19890122
    [No Abstract]   [Full Text] [Related]  

  • 49. Human insulin-induced lipoatrophy. Successful treatment using a jet-injection device.
    Logwin S; Conget I; Jansa M; Vidal M; Nicolau C; Gomis R
    Diabetes Care; 1996 Mar; 19(3):255-6. PubMed ID: 8742573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Injection site lipoatrophy: a rare complication of recombinant human insulin.
    Chakraborty PP; Bhattacharjee R
    J Assoc Physicians India; 2010 Oct; 58():630. PubMed ID: 21510114
    [No Abstract]   [Full Text] [Related]  

  • 51. A case of lipoatrophy with human insulin-therapy.
    Chantelau E; Reuter M; Schotes S; Starke AA
    Exp Clin Endocrinol; 1993; 101(3):194-6. PubMed ID: 8223992
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Picture of the month: insulin-related lipoatrophy].
    Yazdanyar S; Dolmer B; Strauss G
    Ugeskr Laeger; 2011 Aug; 173(33):1968. PubMed ID: 21849139
    [No Abstract]   [Full Text] [Related]  

  • 53. Human insulin-induced lipoatrophy: a successful treatment with glucocorticoid.
    Ramos AJ; Farias MA
    Diabetes Care; 2006 Apr; 29(4):926-7. PubMed ID: 16567840
    [No Abstract]   [Full Text] [Related]  

  • 54. Localized skin reactions to insulin: insulin lipodystrophies and skin reactions to pumped subcutaneous insulin therapy.
    Levandoski LA; White NH; Santiago JV
    Diabetes Care; 1982; 5 Suppl 1():6-10. PubMed ID: 6231169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insulin-mediated lipohypertrophy: an uncommon cause of diabetic ketoacidosis.
    Barola A; Tiwari P; Bhansali A
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28801327
    [No Abstract]   [Full Text] [Related]  

  • 56. A Single-Center Long-Term Continuous Subcutaneous Insulin Infusion (CSII) Experience: Higher Fractional Use Is Associated With Less Diabetes Complications.
    Tubili C; Folco UD; Nardone MR; Clementi A
    J Diabetes Sci Technol; 2017 Sep; 11(5):1057-1058. PubMed ID: 28367635
    [No Abstract]   [Full Text] [Related]  

  • 57. Report of a 7 year case-control study of continuous intraperitoneal insulin infusion and subcutaneous insulin therapy among patients with poorly controlled type 1 diabetes mellitus: favourable effects on hypoglycaemic episodes.
    van Dijk PR; Logtenberg SJ; Groenier KH; Gans RO; Bilo HJ; Kleefstra N
    Diabetes Res Clin Pract; 2014 Nov; 106(2):256-63. PubMed ID: 25305134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin-induced lipodystrophy and interest of insulin injection ports.
    Ben Abdelkrim A; Fathallah N; Omri M; Hasni Y; Khaldi S; Kacem M; Chaieb M; Ben Salem C; Maaroufi A; Ach K
    Therapie; 2019 Dec; 74(6):680-682. PubMed ID: 31088690
    [No Abstract]   [Full Text] [Related]  

  • 59. Severe insulin allergy successfully treated with continuous subcutaneous insulin infusion.
    Fujikawa T; Imbe H; Date M; Go Y; Kitaoka H
    Diabetes Res Clin Pract; 2012 Aug; 97(2):e31-3. PubMed ID: 22609054
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lipoatrophic diabetes mellitus treated by continuous subcutaneous insulin infusion.
    Meyer L; Hadjadj S; Guerci B; Delbachian I; Ziegler O; Drouin P
    Diabetes Metab; 1998 Dec; 24(6):544-6. PubMed ID: 9932222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.